Back to results
RecruitingPhase 2

Bumetanide in Patients With Alzheimer's Disease

NCT06052163

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Stanford University

Stanford, California, United States

View on ClinicalTrials.gov
Bumetanide in Patients With Alzheimer's Disease — TrialFind